Processa Pharmaceuticals, Inc.
PCSA· Nasdaq
PCSAProcessa Pharmaceuticals, Inc.
Filed Nov 8, 2013 · 10-Q · 39 days after period end · 0001393905-13-000601
| Metric | Q3 2013 | Q3 2012 |
|---|---|---|
| Revenue | $125.91K | $49.06K |
| Net Income | -$718.84K | -$601.88K |
| EPS Diluted | -$0.12 | -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Processa Pharmaceuticals, Inc. · CIK 1533743 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 8, 2013 · 39 d after period end
